165 related articles for article (PubMed ID: 29805379)
1. Genetic Background of a Recurrent Unusual Combined Form of Retinal Vein Occlusion: A Case Report.
Bucan K; Plestina Borjan I; Bucan I; Paradzik Simunovic M; Borjan I
Case Rep Ophthalmol; 2018; 9(1):248-253. PubMed ID: 29805379
[TBL] [Abstract][Full Text] [Related]
2. Consecutive central and branch retinal vein occlusions in the same eye of a young healthy COVID-19 patient: A unique case report.
Altıntaş AG; Ekici E
Am J Ophthalmol Case Rep; 2022 Sep; 27():101669. PubMed ID: 35938144
[TBL] [Abstract][Full Text] [Related]
3. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Mitry D; Bunce C; Charteris D
Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND
Retina; 2009 Apr; 29(4):511-5. PubMed ID: 19174717
[TBL] [Abstract][Full Text] [Related]
5. Central retinal vein occlusion in a patient with retinal vasculitis and Crohn's disease.
Figueiredo L; Rothwell R; Brandão A; Fonseca S
Case Rep Ophthalmol Med; 2014; 2014():967878. PubMed ID: 25506451
[TBL] [Abstract][Full Text] [Related]
6. Combination of Intravitreal Corticosteroid with Anti-vegf in Macular Edema Secondary to Retinal Vein Occlusion.
Valašková J; Popov I; Krásnik V
Cesk Slov Oftalmol; 2018; 73(5-6):183-188. PubMed ID: 30541298
[TBL] [Abstract][Full Text] [Related]
7. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
[TBL] [Abstract][Full Text] [Related]
8. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
[TBL] [Abstract][Full Text] [Related]
9. Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusion.
Tilgner E; Dalcegio Favretto M; Tuisl M; Wiedemann P; Rehak M
Acta Ophthalmol; 2017 Nov; 95(7):e592-e596. PubMed ID: 28266152
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
Kim M; Jeong S; Sagong M
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
[TBL] [Abstract][Full Text] [Related]
11. COMBINATION THERAPY OF INTRAVITREAL RANIBIZUMAB AND SUBTHRESHOLD MICROPULSE PHOTOCOAGULATION FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: 6-MONTH RESULT.
Terashima H; Hasebe H; Okamoto F; Matsuoka N; Sato Y; Fukuchi T
Retina; 2019 Jul; 39(7):1377-1384. PubMed ID: 29689025
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
13. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
15. Case Report: A Case of Cystoid Macular Edema in Retinitis Pigmentosa With Central Retinal Vein Occlusion.
Wang DH; Gu C; Yuan YZ
Front Med (Lausanne); 2022; 9():877429. PubMed ID: 35755060
[TBL] [Abstract][Full Text] [Related]
16. Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion.
Wolf-Schnurrbusch UE; Ghanem R; Rothenbuehler SP; Enzmann V; Framme C; Wolf S
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3334-7. PubMed ID: 21087958
[TBL] [Abstract][Full Text] [Related]
17. Management of macular edema with branch retinal vein occlusion in a case of secondary polycythemia.
Singh S; Neriyanuri S; Raman R
GMS Ophthalmol Cases; 2019; 9():Doc38. PubMed ID: 31803567
[No Abstract] [Full Text] [Related]
18. Macular hole formation following intravitreal injection of ranibizumab for branch retinal vein occlusion: a case report.
Muramatsu D; Mitsuhashi R; Iwasaki T; Goto H; Miura M
BMC Res Notes; 2015 Aug; 8():358. PubMed ID: 26285577
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
Ehlers JP; Decroos FC; Fekrat S
Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
[TBL] [Abstract][Full Text] [Related]
20. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
Hu Q; Li H; Xu W; Du Y; Ma C; He J
Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
